Growth Metrics

Anavex Life Sciences (AVXL) Total Non-Current Liabilities (2012 - 2014)

Anavex Life Sciences recorded quarterly Total Non-Current Liabilities of $1.9 million in Q2 2014, up 1.11% quarter-over-quarter from $1.9 million in Q1 2014.

Anavex Life Sciences' Total Non-Current Liabilities history runs 3 years deep, the most recent figure standing at $1.9 million for Q2 2014.

  • In Q2 2014, Total Non-Current Liabilities changed N/A year-over-year to $1.9 million; the TTM figure through Jun 2014 stood at $1.9 million (changed N/A YoY), while the FY2013 annual figure was $2.0 million, down 32.39% from the prior year.
  • Total Non-Current Liabilities came in at $1.9 million for Q2 2014 at Anavex Life Sciences, up from $1.9 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $2.9 million in Q3 2012 to a low of $1.8 million in Q4 2013.
  • A 3-year average of $2.1 million and a median of $1.9 million in 2014 frame the typical range for Total Non-Current Liabilities.
  • On a YoY basis, Total Non-Current Liabilities climbed as much as 32.39% in 2013 and fell as far as 32.39% in 2013.
  • Anavex Life Sciences' Total Non-Current Liabilities stood at $2.9 million in 2012, then tumbled by 36.95% to $1.8 million in 2013, then gained by 4.62% to $1.9 million in 2014.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $1.9 million, $1.9 million, and $1.8 million for Q2 2014, Q1 2014, and Q4 2013 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 11.03 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 42,980.09
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 95.20 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 110.28 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 5.87 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 7.32 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 4.05 Bn
10 Anavex Life Sciences 266.20 Mn 134.45 Mn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2014 1.91 Mn
Mar 31, 2014 1.88 Mn
Dec 31, 2013 1.82 Mn
Sep 30, 2013 1.95 Mn
Sep 30, 2012 2.89 Mn